ImmunityBio, Inc. · HAM:26CA
ImmunityBio, Inc. shareholders
As of Sep 30, 2026, 398 institutions reported holding ImmunityBio, Inc., 19.5% of its shares. Largest: Vanguard, BlackRock and State Street. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of ImmunityBio, Inc. | Change | Filed |
|---|---|---|---|---|
| Vanguard | 41.8M | 3.9% | +5.26M | Nov 16, 2026 |
| BlackRock | 36.1M | 3.4% | +2.04M | Nov 13, 2026 |
| State Street | 21.1M | 2.0% | −303K | Nov 12, 2026 |
| D. E. Shaw & Co., Inc. | 10.7M | 1.0% | −839K | Nov 16, 2026 |
| Geode Capital | 10.6M | 1.00% | +759K | Nov 6, 2026 |
| Two Sigma | 5.83M | 0.55% | −5.27M | Nov 16, 2026 |
| Schwab | 4.93M | 0.46% | +2.05M | Nov 16, 2026 |
| UBS | 4.38M | 0.41% | +655K | Nov 16, 2026 |
| Goldman Sachs | 4.13M | 0.39% | +896K | Nov 16, 2026 |
| Millennium | 3.82M | 0.36% | −1.76M | Nov 16, 2026 |